Press coverage about PetIQ (NASDAQ:PETQ) has been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of press coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. PetIQ earned a news impact score of 0.21 on Accern’s scale. Accern also assigned news articles about the company an impact score of 47.8605922524748 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
PetIQ (NASDAQ:PETQ) traded up $0.22 during mid-day trading on Thursday, reaching $22.20. The company had a trading volume of 191,600 shares, compared to its average volume of 286,526. PetIQ has a fifty-two week low of $17.03 and a fifty-two week high of $28.23. The company has a debt-to-equity ratio of 0.19, a current ratio of 6.83 and a quick ratio of 4.67.
A number of research firms have commented on PETQ. Oppenheimer Holdings, Inc. began coverage on shares of PetIQ in a research report on Tuesday, August 15th. They set an “outperform” rating and a $28.00 price objective for the company. SunTrust Banks, Inc. began coverage on shares of PetIQ in a research report on Tuesday, August 15th. They set a “buy” rating and a $28.00 price objective for the company. William Blair assumed coverage on shares of PetIQ in a research report on Tuesday, August 15th. They set an “outperform” rating for the company. Jefferies Group LLC boosted their target price on shares of PetIQ from $25.00 to $26.00 and gave the company a “hold” rating in a research report on Tuesday, November 7th. Finally, Raymond James Financial, Inc. assumed coverage on shares of PetIQ in a research report on Tuesday, August 15th. They issued an “outperform” rating and a $26.00 target price for the company. Six investment analysts have rated the stock with a buy rating, The company presently has an average rating of “Buy” and an average price target of $27.20.
ILLEGAL ACTIVITY WARNING: “PetIQ (PETQ) Earns Daily Media Impact Rating of 0.21” was first published by Transcript Daily and is owned by of Transcript Daily. If you are accessing this news story on another site, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this news story can be viewed at https://transcriptdaily.com/2017/11/23/petiq-petq-earns-daily-media-impact-rating-of-0-21.html.
PetIQ Company Profile
PetIQ, Inc is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield.
Receive News & Ratings for PetIQ Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ Inc. and related companies with MarketBeat.com's FREE daily email newsletter.